Connection

Manuel Ugarte-Gil to Disease Progression

Back to Details
This is a "connection" page, showing publications Manuel Ugarte-Gil has written about Disease Progression.
Manuel Ugarte-Gil
Connection Strength
0.306
Disease Progression
  1. Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL). Ann Rheum Dis. 2017 Dec; 76(12):2071-2074.
    View in: PubMed
    Score: 0.180
  2. Peripheral CD4+CD28null T-cells as predictors of damage in systemic lupus erythematosus patients. Clin Exp Rheumatol. 2018 Nov-Dec; 36(6):1008-1013.
    View in: PubMed
    Score: 0.047
  3. Remission or low disease activity as a target in systemic lupus erythematosus. Ann Rheum Dis. 2019 01; 78(1):e3.
    View in: PubMed
    Score: 0.046
  4. Epidemiology of systemic lupus erythematosus. Expert Rev Clin Immunol. 2017 08; 13(8):799-814.
    View in: PubMed
    Score: 0.011
  5. Factors predictive of high disease activity early in the course of SLE in patients from a Latin-American cohort. Semin Arthritis Rheum. 2017 10; 47(2):199-203.
    View in: PubMed
    Score: 0.011
  6. Serum uric acid levels contribute to new renal damage in systemic lupus erythematosus patients. Clin Rheumatol. 2017 Apr; 36(4):845-852.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.